ANCA相关性小血管炎性肾损害的治疗分为三个阶段：诱导缓解、维持缓解的治疗以及复发的治疗。诱导期通常维持3~6个月，必须持续至病情缓解为止，病情缓解后维持治疗时间一般持续24个月左右。目前，ANCA相关性小血管炎性肾损害仍无标准的治疗方案，糖皮质激素 ...

Background: Antineutrophil cytoplasmic antibodies (ANCA) with a C-ANCA or P-ANCA pattern are detected in ANCA-associated vasculitis (AAV). While in most patients with AAV a C-ANCA pattern is due to ...

A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.

OSAKA, Japan & BOSTON, MA, USA I June 23, 2025 I Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) and ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

He, L., Zhou, Y., Wang, Q.T., Liu, J. and Ma, J.P. (2025) Two Pathological Patterns in Different Stages of the Same Disease. Journal of Biosciences and Medicines, 13, 189-195. doi: ...

Big pharma companies like Pfizer are making significant investments in antibody-drug conjugates, a promising class of therapies. This article explores the growing interest and recent developments ...

Each laboratory sets its own "critical" titer for anti-D antibody that requires follow-up; this is the titer at which fetal hydrops is likely to occur. The critical titer could be 1:8, 1:16, or 1:32.